Menu
29/11/2005
Grant awarded for breast cancer drug research
A leading Queen's researcher has been granted more than £130,000 to fund research that could one day lead to the development of another breast cancer fighting drug that would have the same affect as Herceptin.
Dr Paul Mullan from the Centre for Cancer Research and Cell Biology is investigating the role of a predictive marker known as TBX2 in breast cancer treatment.
"One of the ways cancer develops is a phenomenon known as gene amplification," Dr Mullan said. "Here the tumour cell makes multiple copies of particular regions of chromosomes which harbour genes important for tumour growth. These cancer causing genes are referred to as oncogenes and in general contribute to uncontrolled cell growth which can form tumours."
There are number of these amplified regions or amplicons in breast cancer. One of the most common amplicons in breast cancer (30%) is the region on chromosome 17 (17q12) which contains the HER2 oncogene. HER2 is the key gene that is responsible for the development of this type of breast cancer and cancer clinicians have specifically targeted this gene using the drug Herceptin.
A region which receives much less attention and is the focus of Dr Mullan's research is chromosome 17 (17q23) which is found in up to 20% of breast cancers.
Dr Mullan explained this region contained another gene which appears to have profound effects on tumour cell growth.
"This oncogene called T-box2 (TBX2) is responsible for switching off other genes and is known to do this in at least two of the major growth control genes which are key in the prevention of cancer. What we know is when TBX2 is amplified it usually means that there is a more aggressive form of breast cancer."
Dr Mullan said his research intended to study the effect of TBX2 in the development of breast cancer and hoped it would one day lead to better treatments. While the work is in its early stages, TBX2 looks to be a promising breast cancer therapeutic target.
(MB/SP)
Dr Paul Mullan from the Centre for Cancer Research and Cell Biology is investigating the role of a predictive marker known as TBX2 in breast cancer treatment.
"One of the ways cancer develops is a phenomenon known as gene amplification," Dr Mullan said. "Here the tumour cell makes multiple copies of particular regions of chromosomes which harbour genes important for tumour growth. These cancer causing genes are referred to as oncogenes and in general contribute to uncontrolled cell growth which can form tumours."
There are number of these amplified regions or amplicons in breast cancer. One of the most common amplicons in breast cancer (30%) is the region on chromosome 17 (17q12) which contains the HER2 oncogene. HER2 is the key gene that is responsible for the development of this type of breast cancer and cancer clinicians have specifically targeted this gene using the drug Herceptin.
A region which receives much less attention and is the focus of Dr Mullan's research is chromosome 17 (17q23) which is found in up to 20% of breast cancers.
Dr Mullan explained this region contained another gene which appears to have profound effects on tumour cell growth.
"This oncogene called T-box2 (TBX2) is responsible for switching off other genes and is known to do this in at least two of the major growth control genes which are key in the prevention of cancer. What we know is when TBX2 is amplified it usually means that there is a more aggressive form of breast cancer."
Dr Mullan said his research intended to study the effect of TBX2 in the development of breast cancer and hoped it would one day lead to better treatments. While the work is in its early stages, TBX2 looks to be a promising breast cancer therapeutic target.
(MB/SP)
Related Northern Ireland News Stories
Click here for the latest headlines.
05 December 2013
NI Highest Breast Cancer Survival In UK
Northern Ireland has the highest breast cancer survival rates in the UK and Ireland, according to research by Queen's University. The data for Northern Ireland was provided by the Queen’s Northern Ireland Cancer Registry to the EUROCARE 5 study. The research is part of a European-wide study into cancer survival rates.
NI Highest Breast Cancer Survival In UK
Northern Ireland has the highest breast cancer survival rates in the UK and Ireland, according to research by Queen's University. The data for Northern Ireland was provided by the Queen’s Northern Ireland Cancer Registry to the EUROCARE 5 study. The research is part of a European-wide study into cancer survival rates.
10 October 2011
Pink Lady Backs NI Cancer Research
A Saintfield woman, Noleen Adair, who knows about cancer, having discovered she had breast cancer at 22 to be faced with radical surgery and chemotherapy has been fundraising. Noleen refuses to put her life on hold and now, the charity she founded to help others facing breast cancer has presented a dazzling £50,000 to Friends of The Cancer Centre.
Pink Lady Backs NI Cancer Research
A Saintfield woman, Noleen Adair, who knows about cancer, having discovered she had breast cancer at 22 to be faced with radical surgery and chemotherapy has been fundraising. Noleen refuses to put her life on hold and now, the charity she founded to help others facing breast cancer has presented a dazzling £50,000 to Friends of The Cancer Centre.
06 November 2003
Belfast women attend cancer awareness meeting
Women from community groups across Belfast attended a Cancer Awareness meeting today to discuss the effect of cancer in their communities and the importance of taking up invitations for Cervical and Breast Screening.
Belfast women attend cancer awareness meeting
Women from community groups across Belfast attended a Cancer Awareness meeting today to discuss the effect of cancer in their communities and the importance of taking up invitations for Cervical and Breast Screening.
09 September 2011
Yellowhammer Portraits Are Framing Success
Two local cancer charities, the Ulster Cancer Foundation (UCF) and Friends of the Cancer Centre, have announced a unique fundraising initiative - the opportunity to buy a highly collectable piece of art by acclaimed Irish artist, Nicola Russell, while making a significant contribution to the work of both charities.
Yellowhammer Portraits Are Framing Success
Two local cancer charities, the Ulster Cancer Foundation (UCF) and Friends of the Cancer Centre, have announced a unique fundraising initiative - the opportunity to buy a highly collectable piece of art by acclaimed Irish artist, Nicola Russell, while making a significant contribution to the work of both charities.
10 October 2001
Call for more information on smoking health risks
With this week focusing on women and cancer a local councillor has spoken out and has called for more information to be made to women about the risks of smoking to their health.
Call for more information on smoking health risks
With this week focusing on women and cancer a local councillor has spoken out and has called for more information to be made to women about the risks of smoking to their health.
-
Northern Ireland WeatherToday:A showery start with outbreaks most frequent north of Lough Neagh and through the morning, before dwindling during the afternoon as the northwest breezes ease and brighter spells of weak sunshine prosper. Maximum temperature 8 °C.Tonight:A dry night, save for a few light showers around the coasts, with prolonged clear spells and light winds bringing a frosty dawn for many in central and southern parts. Minimum temperature -3 °C.
